Clinical Trial Update: Subclinical Atherosclerosis in HIV-infected Patients

View source ↗

Summary

A completed Massachusetts General Hospital clinical trial investigating subclinical atherosclerosis in HIV-infected patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Atherosclerosis
• HIV Infection

Snippet

Sponsor: Massachusetts General Hospital | Conditions: HIV Infections, Coronary Atherosclerosis | Status: COMPLETED